Home Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay
Article
Licensed
Unlicensed Requires Authentication

Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay

  • Marijke Reynders , Ellen Anckaert , Johan Schiettecatte and Johan Smitz
Published/Copyright: September 21, 2011

Abstract

Serum sex hormone-binding globulin (SHBG) regulates the cellular bioavailability of SHBG-bound steroid hormones. Since variations in SHBG levels may affect the concentration of free, i.e., biologically active testosterone in serum, SHBG levels are commonly measured as a supplement to total testosterone determination. The recently developed electrochemiluminescence Elecsys ® SHBG immunoassay was evaluated analytically on a Modular E170 (Roche Diagnostics, Mannheim, Germany) immunoanalyzer. Major differences in SHBG concentrations have been described among the commercially available methods; we therefore compared the new method with an established SHBG immunoradiometric assay (IRMA) in 99 routine serum samples. To provide reference values to clinicians, SHBG concentration was measured by Elecsys ® in 304 serum samples from healthy volunteers and several relevant clinical subgroups. The within-run and total imprecision coefficients of variation were ≤2.9% and ≤3.3%, respectively. Functional sensitivity was at least 0.74nmol/L. Recoveries after dilution of high-concentration samples in low-titer human serum or in assay diluent were within the range of 85–110%. The Elecsys ® SHBG assay correlated well (r=0.98) with the SHBG immunoradiometric assay, but values were higher for the Elecsys ® assay (Passing Bablok regression analysis: slope 1.14, intercept +2.5). In healthy subjects and clinical subgroups, we confirmed the differences in SHBG values reported in the literature. The Elecsys ® SHBG immunoassay provides precision and reliability in combination with reduced turnaround time.


Corresponding author: Ellen Anckaert, RIA Laboratorium, Laarbeeklaan 101, 1090 Brussels, Belgium Phone: +32-2-4775057, Fax: +32-2-4775060,

References

1 Pugeat M, Crave JC, Tourniaire J, Forest MG. Clinical utility of sex hormone-binding globulin measurement. Horm Res 1996; 45: 148–55. 10.1159/000184778Search in Google Scholar

2 Anderson DC. Sex hormone-binding globulin. Clin Endocrinol 1974; 3: 69–96. 10.1111/j.1365-2265.1974.tb03298.xSearch in Google Scholar

3 Vaysse J, Beaugrand M, Pontet M. Measurements of total and desialylated sex hormone-binding globulin in serum by ELISA. Clin Chem 1998; 44: 882–4. 10.1093/clinchem/44.4.882Search in Google Scholar

4 Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666–72. 10.1210/jcem.84.10.6079Search in Google Scholar

5 Bukowski C, Grigg MA, Longcope C. Sex hormone-binding globulin concentration: differences among commercially available methods. Clin Chem 2000; 46: 1415–6. 10.1093/clinchem/46.9.1415Search in Google Scholar

6 Elmlinger MW, Kuhnel W, Ranke MB. Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults. Clin Chem Lab Med 2002; 40: 1151–60. 10.1515/cclm.2002.202Search in Google Scholar

7 Wayne PA. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS Document EP5-A 1999; 19: 1–11. Search in Google Scholar

8 Maruyama Y, Aoki N, Suzuki Y, Ohno Y, Imamura M, Saika T, et al. Sex steroid-binding plasma protein, testosterone, oestradiol, and dehydroepiandrosterone in prepuberty and puberty. Acta Endocrinol (Copenh) 1987; 114: 60–7. 10.1530/acta.0.1140060Search in Google Scholar

9 Bartsch W, Horst HJ, Derwhal KM. Interrelationships between sex hormone-binding globulin and 17β-oestradiol, testosterone, 5α-dihydrotestosterone, thyroxine and triiodothyronine in prepubertal and pubertal girls. J Clin Endocrinol Metab 1980; 50: 1053–6. 10.1210/jcem-50-6-1053Search in Google Scholar

10 Blank B, Attanasio A, Rager K, Gupta D. Determination of serum sex hormone-binding globulin in preadolescent and adolescent boys. J Steroid Biochem 1978; 9: 121–5. 10.1016/0022-4731(78)90071-7Search in Google Scholar

11 Bedecarras P, Gryngarten M, Ayuso S, Escobar ME, Bergada C, Campo S. Characterization of serum SHBG isoforms in prepubertal and pubertal girls. Clin Endocrinol 1998; 49: 603–8. 10.1046/j.1365-2265.1998.00574.xSearch in Google Scholar PubMed

12 Wuu J, Hellerstein S, Lipworth L, Wide L, Xu B, Yu GP, et al. Correlates of pregnancy estrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev 2002; 11: 283–93. 10.1097/00008469-200206000-00012Search in Google Scholar

13 Uriel J, Dupiers M, Rimbaut C, Buffe D. Maternal serum levels of sex steroid-binding protein during pregnancy. Br J Obstet Gynaecol 1981; 88: 1229–32. 10.1111/j.1471-0528.1981.tb01202.xSearch in Google Scholar

14 Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause – a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999; 78: 642–7. Search in Google Scholar

15 Serin IS, Ozcelik B, Basbug M, Aygen E, Kula M, Erez R. Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels. Eur J Obstet Gynecol Reprod Biol 2001; 99: 222–25. 10.1016/S0301-2115(01)00398-0Search in Google Scholar

16 Nachtigall LE, Raju U, Banerjee S, Wan L, Levitz M. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels. Menopause 2000; 7: 243–50. 10.1097/00042192-200007040-00006Search in Google Scholar PubMed

17 Hampl R, Kancheva R, Hill M, Bicikova M, Vondra K. Interpretation of sex hormone-binding globulin levels in thyroid disorders. Thyroid 2003; 13: 755–60. 10.1089/105072503768499644Search in Google Scholar PubMed

18 Brenta G, Schnitman M, Gurfinkiel M, Damilano S, Pierini A, Sinay Pisarev MA. Variations of sex hormone-binding globulin in thyroid dysfunction. Thyroid 1999; 9: 273–7. 10.1089/thy.1999.9.273Search in Google Scholar PubMed

Received: 2004-4-22
Accepted: 2004-10-7
Published Online: 2011-9-21
Published in Print: 2005-1-1

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Pathophysiology and diagnostic value of urinary trypsin inhibitors
  2. Apolipoprotein H (apoH)-dependent autoantibodies and apoH protein polymorphism in selected patients showing lupus anticoagulant activity
  3. Differential production of immunoglobulin classes and subclasses by mucosal-type human B-lymphocytes exposed in vitro to CpG oligodeoxynucleotides
  4. The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma
  5. The soluble transferrin receptor (sTfR)-ferritin index is a potential predictor of celiac disease in children with refractory iron deficiency anemia
  6. Monitoring of fibrinolysis parameters during myocardial revascularization according to type of procedure
  7. Serum amyloid A protein levels as a possible aid in the diagnosis of acute appendicitis in children
  8. External failures as descriptor of quality in clinical microbiology laboratory services
  9. The effects of extracorporeal cardiopulmonary circulation on serum total and free prostate specific antigen levels
  10. Quantitative automated human chorionic gonadotropin measurement in urine using the Modular Analytics E170 module (Roche)
  11. Interference of dextran in biuret-type assays of serum proteins
  12. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport
  13. Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay
  14. The late Greco-Roman and Byzantine contribution towards the evolution of laboratory examinations of bodily excrement. Part 2: sputum, vomit, blood, sweat, autopsies
  15. Faecal elastase 1 measurement in chronic pancreatitis
  16. On the origin of BÄK requirements for imprecision
  17. Reference intervals for serum thyrotropin (TSH) and free thyroxine (FT4) in adults using the Access ® Immunoassay System
  18. Erythrocyte glutathione and serum total glutathione-S-transferase in epilepsy
  19. CCLM - Guidelines for Authors
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.013/html
Scroll to top button